Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2 billion
Mallinckrodt plc, a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, have entered into an agreement under... Read More